Average Co-Inventor Count = 7.41
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sirna Therapeutics, Inc. (8 from 138 patents)
2. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
9 patents:
1. 11932854 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
2. 11193126 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
3. 10246714 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
4. 9970005 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
5. 9850491 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
6. 9447420 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA)
7. 9260471 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
8. 8835623 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
9. 8518907 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)